(Q43427058)

23 November 2017

title

Prognostic value of c-erbB2 expression in breast cancer (English)

1 reference

23 November 2017

2

Shinji Ohno

1 reference

23 November 2017

Shinichi Tsutsui

1

1 reference

23 November 2017

Shigeru Murakami

series ordinal

3

1 reference

23 November 2017

Yoichi Hachitanda

series ordinal

4

1 reference

23 November 2017

Shinya Oda

series ordinal

5

1 reference

23 November 2017

publication date

1 April 2002

1 reference

Journal of Surgical Oncology

23 November 2017

published in

1 reference

23 November 2017

volume

79

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

216-223

1 reference

The neu oncogene encodes an epidermal growth factor receptor-related protein

23 November 2017

cites work

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review

21 January 2018

1 reference

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

21 January 2018

1 reference

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer

21 January 2018

1 reference

Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression

21 January 2018

1 reference

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

21 January 2018

1 reference

HER-2/neu oncogene protein and prognosis in breast cancer

21 January 2018

1 reference

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

21 January 2018

1 reference

Prognostic significance of c-erbB-2 expression in node negative breast cancer

21 January 2018

1 reference

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

21 January 2018

1 reference

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

21 January 2018

1 reference

Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.

21 January 2018

1 reference

ERBB2 oncogene in human breast cancer and its clinical significance

21 January 2018

1 reference

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

21 January 2018

1 reference

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

21 January 2018

1 reference

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

21 January 2018

1 reference

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

21 January 2018

1 reference

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

21 January 2018

1 reference

c-erbB-2 protein expression in node negative breast cancer

21 January 2018

1 reference

MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo

21 January 2018

1 reference

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

21 January 2018

1 reference

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

21 January 2018

1 reference

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

21 January 2018

1 reference

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.10079

1 reference

release_xyl3i4ltnngehlhdbuoiw5ucrq

23 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xyl3i4ltnngehlhdbuoiw5ucrq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference